Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14457875 | 0.91 | CA2 (0.38) | CTDSP1CA2MEN1LMNAKMT2A | |
| SCHEMBL16669702 | 0.84 | CTDSP1 (0.38) | CTDSP1CA2CYP2D6SLC6A2SLC6A4 | |
| SCHEMBL25691501 | 0.81 | MEN1 (0.37) | CTDSP1CA2MEN1LMNAKMT2A | |
| SCHEMBL13620111 | 0.79 | SPHK2 (0.32) | CA2 | |
| SCHEMBL1786903 | 0.78 | CA2 (0.54) | CA2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL1487288 | 0.78 | CA2 (0.54) | CA2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL12967131 | 0.78 | CA2 (0.54) | CA2CYP2D6SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24065927 | 0.77 | CHRM2 (0.34) | CTDSP1CA2MEN1LMNAKMT2A | |
| SCHEMBL14342995 | 0.77 | CHRM2 (0.34) | CTDSP1CA2MEN1LMNAKMT2A | |
| SCHEMBL14457149 | 0.76 | CA2 (0.34) | CTDSP1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090292093-A1 | FLUORINATED COMPOUND AND FLUORINATED POLYMER | ASAHI GLASS COMPANY, LIMITED (JP) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292093-A1 | FLUORINATED COMPOUND AND FLUORINATED POLYMER | AFF2, RFC2, RFC3 | CTDSP1 789/4885CA2 3315/4885CYP2D6 3616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.